Enveric Biosciences Inc (ENVB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -10.427 | -24.348 | -47.611 | -22.071 | -47.179 | -317.867 | -81.259 | -146.388 |
Return on Equity (%) | -46.649 | -71.767 | -128.983 | -56.408 | -97.813 | -380.818 | -101.682 | -209.995 |
Return on Invested Capital (%) | -21.79 | -51.691 | 0.788 | -42.898 | -80.083 | -161.423 | -102.249 | -186.262 |
Operating Margin (%) | -15.974 | -22.414 | -22.838 | -11.334 | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -7.694 | -22.974 | -45.307 | -15.107 | N/A | N/A | N/A | N/A |
Book Value Per Share | -1.022 | -0.643 | -0.205 | -2.277 | 0.117 | 0.353 | 7.304 | 0.752 |
Earnings Per Share | -0.2 | -0.602 | -0.456 | -2.05 | -0.513 | -1.252 | -9.047 | -7.522 |
Cash Per Share | 0.099 | 0.263 | 0.032 | 0.147 | 0.118 | 0.444 | 8.529 | 0.986 |
Working Capital Per Share | -0.19 | -0.848 | -0.108 | -2.307 | 0.12 | 0.4 | 6.947 | 0.533 |
Operating Profit Per Share | 0.471 | 0.552 | 0.372 | 2.772 | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.47 | -0.618 | -0.247 | -1.773 | -0.513 | -1.442 | -9.604 | -7.438 |
EBITDA Per Share | -0.47 | -0.618 | -0.247 | -1.773 | -0.513 | -1.442 | -9.604 | -7.438 |
Free Cash Flow Per Share | -0.033 | -0.775 | -0.524 | -2.792 | -0.51 | -1.246 | -8.924 | -7.668 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 13,89M | 18,16M | 42,33M | 2,52M | 10,1M | 32,58M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 4,14M |
Ratio cours/bénéfice | -0,23 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,74 |
Ratio prix/valeur comptable | 2,03 |
Rendement de dividende | - |
Actions en circulation | 9,94M |
Volume moyen (1 semaine) | 1,2M |
Volume moyen (1 mois) | 611,94k |
Variation sur 52 semaines | -69,62% |
Plus haut sur 52 semaines | 2,92 |
Plus bas sur 52 semaines | 0,2955 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales